Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation
|
Eliem Therapeutics, Inc. (ELYM)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/21/2023 |
3
| Pimblett Emily (Chief Accounting Officer) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| AI ETI LLC (10% Owner) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| Dunn Judith (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| PATTERSON LEONE D (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| Ratcliffe Liam (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| Rosenberg Adam Joseph (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| Tate Simon (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| Levin Andrew David (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| Bucher James B (EVP and General Counsel) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| Lavelle Erin (COO & CFO) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| Morisset Valerie (Chief Scientific Officer) has filed a Form 3 on Eliem Therapeutics, Inc. |
08/09/2021 |
3
| Azelby Robert (CEO) has filed a Form 3 on Eliem Therapeutics, Inc. |
|
|